Pancreatic acinar-like adenocarcinoma of the proximal stomach invading the esophagus

Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Qiang Zhou(Nanjing Drum Tower Hospital), Jiong Shi(Nanjing Drum Tower Hospital), Hongyan Wu(Hong Kong Baptist University), An‐Ning Feng(Nanjing Drum Tower Hospital), Jason S. Gold(Memorial Sloan Kettering Cancer Center), Xiangshan Fan(Anhui Medical University)
Human Pathology
November 4, 2011
10.1016/j.humpath.2011.07.024
Cited by 10

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
|The Lancet Oncology|2009|511
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362